Cargando…

Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence

Antiseizure medications are the cornerstone pharmacotherapy for epilepsy. They are not devoid of side effects. In search for better-tolerated antiseizure agents, cannabinoid compounds and other N-acylethanolamines not directly binding cannabinoid receptors have drawn significant attention. Among the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bortoletto, Riccardo, Balestrieri, Matteo, Bhattacharyya, Sagnik, Colizzi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773576/ https://www.ncbi.nlm.nih.gov/pubmed/35053844 http://dx.doi.org/10.3390/brainsci12010101

Ejemplares similares

Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence
por: Bortoletto, Riccardo, et al.
Publicado: (2023)

The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System
por: Colizzi, Marco, et al.
Publicado: (2022)

Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence
por: Colizzi, Marco, et al.
Publicado: (2022)

Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence
por: Colizzi, Marco, et al.
Publicado: (2021)

Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2022)

Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
por: Bosco, Francesca, et al.
Publicado: (2023)

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
por: Colizzi, Marco, et al.
Publicado: (2017)

Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior
por: Colizzi, Marco, et al.
Publicado: (2020)

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
por: Lang-Illievich, Kordula, et al.
Publicado: (2023)

Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies
por: Yang, Chih-Sheng, et al.
Publicado: (2023)

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis
por: Lattanzi, Simona, et al.
Publicado: (2022)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
por: Colizzi, Marco, et al.
Publicado: (2020)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
por: Facchinetti, Roberta, et al.
Publicado: (2020)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
por: Cordaro, Marika, et al.
Publicado: (2020)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry
por: De Gregorio, Danilo, et al.
Publicado: (2021)

The Effectiveness of Lurasidone Add-On for Residual Aggressive Behavior and Obsessive Symptoms in Antipsychotic-Treated Children and Adolescents with Tourette Syndrome: Preliminary Evidence from a Case Series
por: Colizzi, Marco, et al.
Publicado: (2021)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
por: Valenza, Marta, et al.
Publicado: (2022)

A Preclinical Systematic Review and Meta-Analysis of Behavior Testing in Mice Models of Ischemic Stroke
por: Boboc, Ianis Kevyn Stefan, et al.
Publicado: (2023)

The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?
por: Gunasekera, Charlene L., et al.
Publicado: (2023)

Teratogenicity and Antiseizure Medications
por: Meador, Kimford
Publicado: (2020)

Antiseizure medications and pregnancy
por: Moores, Ginette, et al.
Publicado: (2021)

Neuropharmacology of Antiseizure Drugs
por: Hakami, Tahir
Publicado: (2021)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Therapeutic Potential of Exosomes in Tendon and Tendon–Bone Healing: A Systematic Review of Preclinical Studies
por: Zou, Mingrui, et al.
Publicado: (2023)

Commentary on “Antiseizure activity by opioid receptor antagonism, new evidence”
por: de Witte, Peter
Publicado: (2022)

Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
por: Bortoletto, Riccardo, et al.
Publicado: (2022)

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans
por: Colizzi, Marco, et al.
Publicado: (2019)

Efficacy and tolerability of antiseizure drugs
por: Hakami, Tahir
Publicado: (2021)

Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2022)

Antitumor Properties of Curcumin in Breast Cancer Based on Preclinical Studies: A Systematic Review
por: Barcelos, Kênia Alves, et al.
Publicado: (2022)

Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
por: Sudarmaji, Nurizzati, et al.
Publicado: (2022)

Anti-Inflammatory, Antioxidant, and Skin Regenerative Potential of Secondary Metabolites from Plants of the Brassicaceae Family: A Systematic Review of In Vitro and In Vivo Preclinical Evidence (Biological Activities Brassicaceae Skin Diseases)
por: Mattosinhos, Patricia da Silva, et al.
Publicado: (2022)

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease
por: Beggiato, Sarah, et al.
Publicado: (2019)

S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE
por: Colizzi, Marco, et al.
Publicado: (2018)

Possible Anandamide and Palmitoylethanolamide involvement in human stroke
por: Naccarato, Marcello, et al.
Publicado: (2010)

Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms
por: Bajalia, Essa M., et al.
Publicado: (2022)

Educational intervention to improve preclinical academic performance: A systematic review
por: Ahmady, Soleiman, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7qaqokgci2r86mrtu9pqmtrgga